68ga-nodaga-zigf-1r:4
mAbexperimentalImaging agent
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2016 (NCT02916394)
Timeline
No events for the selected filters.
Mechanism of action
- Insulin-like growth factor I receptorRadiodepletion
IGF1R radiodepletion
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 68-Gallium
Oral
No
Parenteral
No
Topical
No
Also known as
- 68ga-nodaga-zigf-1r:4
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02916394 | N/A | Sep 1, 2016 | Harbin Medical University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harbin Medical University | Academic/Hospital | 1 | 1 | 1 | 2016 |
1 organizations
Page 1 / 1